SCHEMBL5137750

SCHEMBL5137750

CCCCOC(=O)c1cc(N)ccc1N

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.68
HSD17B10 Q99714 2/20 0.68
TSHR P16473 8/20 0.62
CYP1A2 P05177 5/20 0.62
CYP3A4 P08684 4/20 0.62
LMNA P02545 4/20 0.62
CYP2C19 P33261 2/20 0.62
CYP2C9 P11712 1/20 0.62
PDE4D Q08499 1/20 0.62
POLB P06746 2/20 0.60
KDM4E B2RXH2 2/20 0.60
TDP1 Q9NUW8 3/20 0.58
L3MBTL1 Q9Y468 2/20 0.58
MAPT P10636 2/20 0.55
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
MAPK1 P28482 3/20 0.53
TP53 P04637 1/20 0.53
CYP2D6 P10635 4/20 0.50
SCN1A P35498 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5181901 0.94 ALDH1A1 (0.69) ALDH1A1HSD17B10TSHRCYP1A2CYP3A4
SCHEMBL22773392 0.94 ALDH1A1 (0.69) ALDH1A1HSD17B10TSHRCYP1A2CYP3A4
SCHEMBL29204388 0.90 ALDH1A1 (0.56) ALDH1A1HSD17B10TSHRCYP1A2CYP3A4
SCHEMBL7734044 0.89 TSHR (0.65) ALDH1A1HSD17B10TSHRCYP1A2CYP3A4
SCHEMBL11109738 0.88 ALDH1A1 (0.68) ALDH1A1HSD17B10TSHRCYP1A2CYP3A4
SCHEMBL7530338 0.88 ALDH1A1 (0.68) ALDH1A1HSD17B10TSHRCYP1A2CYP3A4
SCHEMBL7159501 0.86 ALDH1A1 (0.66) ALDH1A1HSD17B10TSHRCYP1A2CYP3A4
SCHEMBL9363450 0.86 TSHR (0.60) ALDH1A1HSD17B10TSHRCYP1A2CYP3A4
SCHEMBL28326757 0.85 ALDH1A1 (0.68) ALDH1A1HSD17B10TSHRCYP1A2CYP3A4
SCHEMBL11506341 0.85 ALDH1A1 (0.64) ALDH1A1HSD17B10TSHRCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1933841-A1 COMBINATION THERAPY COMPRISING SUBSTITUTED OXAZOLIDINONES FOR THE PREVENTION AND TREATMENT OF CEREBRAL CIRCULATORY DISORDERS Bayer HealthCare AG (DE) 2008-06-25 EP disclosed
WO-2007039134-A1 COMBINATION THERAPY COMPRISING SUBSTITUTED OXAZOLIDINONES FOR THE PREVENTION AND TREATMENT OF CEREBRAL CIRCULATORY DISORDERS BAYER HEALTHCARE AG (DE) 2007-04-12 WO disclosed